Suri Technologies

Stealth mode

Health Tech & Life Sciences

Stealth Mode

Pre-Funding Ramot HaShavim Founded 2014

Total raised

—

Stage

Pre-Funding

Founded

2014

Headcount

6

HQ

Ramot HaShavim

Sector

Health Tech & Life Sciences

About

Establishment of a new field of anti-cancer treatment. Development new personalized cancer treatment, by producing new personalized autoantibodies drug specifically to every patient.

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is the primary focus of Suri Technologies' anti-cancer treatment development?: Suri Technologies is focused on developing personalized cancer treatments by producing new personalized autoantibodies drugs specifically for each patient.
When was Suri Technologies founded?: Suri Technologies was founded in January 2014.
What is the current operational status of Suri Technologies?: Suri Technologies is currently inactive, having ceased operations in December 2019.
Where is Suri Technologies headquartered?: Suri Technologies is headquartered in Ramot HaShavim, Israel, at HaBroshim Street 10.
How many employees did Suri Technologies have?: Suri Technologies had between 1 and 10 employees, with an exact count of 6.
What is Suri Technologies' primary sector classification?: Suri Technologies' primary sector classification is Health Tech & Life Sciences.
Who is a known founder of Suri Technologies?: Ilan Hochman is a founder of Suri Technologies.
What was the product stage of Suri Technologies?: Suri Technologies was in the customer development product stage.
Did Suri Technologies secure any funding?: According to startupim data, Suri Technologies had not raised any funding, with a total raised of $0 USD.
Does Suri Technologies hold any patents?: Yes, Suri Technologies holds 1 patent related to personalized cancer treatment using patient antibodies, which was established on January 1, 2014.

Sectors & technology

Primary sector

Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development

Target customers

Healthcare & Life SciencesLife SciencesPharmaceuticals

Business model

B2B

Highlights

1 Patents

Tags

oncologyantibodiestreatmentsdrug-developmentcancer-therapypharma-companiespersonalizationstealthmode

Suri Technologies — Full Company Profile (machine-readable)

Stealth mode

About

Establishment of a new field of anti-cancer treatment. Development new personalized cancer treatment, by producing new personalized autoantibodies drug specifically to every patient.

Facts

Name	Suri Technologies
Slug	suri-technologies
Type	Israeli Startup
Founded	2014
HQ city	Ramot HaShavim
HQ country	IL
Primary sector	[object Object]
Sectors	[object Object], [object Object], [object Object]
Business models	B2B
Target customers	[object Object], [object Object], [object Object]
Status	inactive
Current stage	Pre-Funding
Public stage	Pre-Funding
Total raised (USD)	0
Israeli Companies Registrar	514140896

Team (1)

Name	Role	LinkedIn
Ilan Hochman

Intelligence Q&A

What is the primary focus of Suri Technologies' anti-cancer treatment development?

Suri Technologies is focused on developing personalized cancer treatments by producing new personalized autoantibodies drugs specifically for each patient.

When was Suri Technologies founded?

Suri Technologies was founded in January 2014.

What is the current operational status of Suri Technologies?

Suri Technologies is currently inactive, having ceased operations in December 2019.

Where is Suri Technologies headquartered?

Suri Technologies is headquartered in Ramot HaShavim, Israel, at HaBroshim Street 10.

How many employees did Suri Technologies have?

Suri Technologies had between 1 and 10 employees, with an exact count of 6.

What is Suri Technologies' primary sector classification?

Suri Technologies' primary sector classification is Health Tech & Life Sciences.

Who is a known founder of Suri Technologies?

Ilan Hochman is a founder of Suri Technologies.

What was the product stage of Suri Technologies?

Suri Technologies was in the customer development product stage.

Did Suri Technologies secure any funding?

According to startupim data, Suri Technologies had not raised any funding, with a total raised of $0 USD.

Does Suri Technologies hold any patents?

Yes, Suri Technologies holds 1 patent related to personalized cancer treatment using patient antibodies, which was established on January 1, 2014.